Nitrocamptothecin in Treating Patients With Recurrent Non-small Cell Lung Cancer

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of nitrocamptothecin in treating patients who have recurrent non-small cell lung cancer.

Timeline

Start

1999-05

Primary completion

—

Completion

2004-04

Drugs

Indications